CHM chimeric therapeutics limited

Ann: CHM 1101 data accepted for presentation at SNO meeting, page-98

  1. 176 Posts.
    lightbulb Created with Sketch. 180
    having just watched the video of today’s seminar is seems like quite a reasonable amount of de-risking has occurred although I suspect a few are waiting for the details to be presented at the end of this week.
    overall I think we have some market challenges due to the relatively low liquidity of the stock. Ii suspect some investors would be a little concerned by this as it makes it difficult for them to buy a reasonable position. Even thought the trading volume was up today, it’s still pretty minor and I think it will stay that way with a fairly small register we have today.

    overall, I’m much happier with my investment today than last week and will look to acquire a bit more. Very happy about the no immunogenicity being reported.

    cheers - YS
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $20.21K 5.053M

Buyers (Bids)

No. Vol. Price($)
2 2213046 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 13563373 20
View Market Depth
Last trade - 15.01pm 24/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.